Kodiak Sciences Inc. (KOD)
$81.09-11.50%Close
BUYCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $5.1B
- Beta
- 2.04
- P/E (TTM)
- -19.35
- Short % float
- 19.14%
- Days to cover
- 1.8
- SI change
- -12.2%
- 1W
- -10.97%
- 1M
- +145.80%
- vs SPY 1W
- -9.99%
- vs SPY 1M
- +143.94%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on KOD?
- LOPJLB’s latest quantitative signal on Kodiak Sciences Inc. (KOD) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is KOD in?
- Kodiak Sciences Inc. (KOD) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Kodiak Sciences Inc. (KOD) do?
- Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, …